| Current Price | $42.79 | Mkt Cap | $243.2B |
|---|---|---|---|
| Open | $43.23 | P/E Ratio | 21.71 |
| Prev. Close | $42.79 | Div. (Yield) | $1.56 (3.6%) |
| Daily Range | $42.62 - $43.30 | Volume | 28,982,107 |
| 52-Wk Range | $33.36 - $43.74 | Avg. Daily Vol. | 23,351,546 |
A research-based pharmaceutical company, Pfizer discovers, develops, manufactures, and markets prescription medicines such as Lipitor, Celebrex, and Viagra.
| Current Price | $42.79 | Mkt Cap | $243.2B |
|---|---|---|---|
| Open | $43.23 | P/E Ratio | 21.71 |
| Prev. Close | $42.79 | Div. (Yield) | $1.56 (3.6%) |
| Daily Range | $42.62 - $43.30 | Volume | 28,982,107 |
| 52-Wk Range | $33.36 - $43.74 | Avg. Daily Vol. | 23,351,546 |
The best Bull and Bear pitches based on recency and number of recommendations.
The stock has been underperforming for a while now. AstraZeneca and other pharma-peers are showing a nice growth(in stock price). The recent fail of Pfizer to take over AstraZeneca(AZN) and nothing special in the works, only proves to me that for the… More
Read the most recent pitches from players about PFE.
Recs
TMFkodyk123
(54.06)
Submitted: 7/28/2021 11:53:46 AM :
Start Price:
$43.01
NYSE:PFE Score:
-0.86
Even without the company's COVID-19 vaccine (which appears to be here to stay for the foreseeable future itself), Pfizer's operational revenue grew by double-digits year-over-year. The company's interest coverage ratio improved tremendously from 8 to nearly 22 year-over-year. Finally, the payout ratio below 40% suggests the dividend is safe for income investors.
Recs
3PFE9
(< 20)
Submitted: 6/7/2021 9:07:00 PM :
Start Price:
$38.72
NYSE:PFE Score:
+6.36
Yes with mRNA
Recs
mabrick
(57.00)
Submitted: 4/10/2021 5:53:05 PM :
Start Price:
$35.69
NYSE:PFE Score:
+12.74
Many products, and more coming.
Find the members with the highest scoring picks in PFE.
flickib41 (71.36) Score: +179.69
The Score Leader is the player with the highest score across all their picks in PFE.
|
Top Pick |
Member Name |
Member Rating |
Start Date |
Call |
Time Frame |
Start Price |
Stock Gain |
Index Gain |
Score | Commentary |
|---|---|---|---|---|---|---|---|---|---|---|
| webwhat | 96.67 | 1/26/2009 |
|
5Y | $10.10 | +323.87% | +436.45% | +112.58 | 0 Comment | |
| efpatentit | < 20 | 12/29/2008 |
|
3Y | $10.46 | +308.91% | +420.41% | +111.50 | 0 Comment | |
| bobbyvee | 75.70 | 3/9/2009 |
|
3Y | $7.75 | +452.16% | +559.73% | +107.57 | 1 Comment | |
| infiniti2004 | < 20 | 1/2/2009 |
|
1Y | $10.96 | +290.46% | +395.82% | +105.36 | 0 Comment | |
| chodge | < 20 | 12/31/2008 |
|
1Y | $10.87 | +293.80% | +398.00% | +104.20 | 0 Comment | |
| rockambo | < 20 | 12/5/2008 |
|
3M | $9.87 | +333.61% | +436.57% | +102.97 | 1 Comment | |
| Asaad08 | 48.94 | 12/18/2008 |
|
1Y | $10.56 | +305.19% | +404.57% | +99.38 | 1 Comment | |
| Malone3212 | 64.73 | 3/5/2009 |
|
1Y | $7.78 | +449.95% | +548.74% | +98.78 | 0 Comment | |
| frugalpro | < 20 | 12/18/2008 |
|
5Y | $10.66 | +301.26% | +397.27% | +96.01 | 1 Comment | |
|
harjono | 61.52 | 3/18/2009 |
|
NS | $8.89 | +381.07% | +476.34% | +95.27 | 0 Comment |
See what the Wall Street professionals think, according to their public statements and filings.
